HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1,3,6,8,10,13,16,19- octaazabicyclo- 6,6,6- eicosanecobalt(II)

reducing agent

Also Known As:

Co(sep)

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Organometallic Compounds: 64
  - 1,3,6,8,10,13,16,19-octaazabicyclo-6,6,6-eicosanecobalt(II): 2

Experts

1.	Chen, Zhi-juan: 1 article (10/2010)
2.	Hao, Zhi-dong: 1 article (10/2010)
3.	Li, Hong: 1 article (10/2010)
4.	Wang, Zeng-guang: 1 article (10/2010)
5.	Yang, Wei-dong: 1 article (10/2010)
6.	Yu, Qing: 1 article (10/2010)
7.	Zhang, Cheng-zhou: 1 article (10/2010)

Related Diseases

1.	Epilepsy (Aura) 10/26/2010 - "BOLD-fMRI and Co-SEP, MEP and ECoG are complementary in M1 of secondary epilepsy surgery. " 09/01/1990 - "Evoked potential (Co-SEP) during operation in surgery for epilepsy and intracranial tumor."
2.	Neoplasms (Cancer) 09/01/1990 - "Evoked potential (Co-SEP) during operation in surgery for epilepsy and intracranial tumor." 09/01/1990 - "In conclusion, Co-SEP under general anesthesia is feasible and recommended to be performed as a routine intraoperatively for intractable epilepsy and tumor originating close to the primary motor or sensory strip in order to avoid iatrogenic damage to the vital cerebral cortex."
3.	Drug Resistant Epilepsy 09/01/1990 - "In conclusion, Co-SEP under general anesthesia is feasible and recommended to be performed as a routine intraoperatively for intractable epilepsy and tumor originating close to the primary motor or sensory strip in order to avoid iatrogenic damage to the vital cerebral cortex."

Related Therapies and Procedures

1.	General Anesthesia